Ayurveda, yoga effective in high-risk Covid treatment: Study | India News


NEW DELHI: A joint team of researchers from the IIT-Delhi and Dev Sanskriti Vishwavidyalaya, Haridwar, have found that yoga and ayurveda may be effective in the treatment of high-risk cases of Covid-19 following a research study on successful treatment of 30 high-risk patients. Besides the standard care treatment as per guidelines, the patients were prescribed ayurvedic medicines through telemedicine, and administered a personalised therapeutic yoga programme using video conferencing. Almost all the patients were classified as high-risk owing to one or more of co-morbidities such as diabetes mellitus, hypertension, chronic kidney disease, coronary artery disease which are known to lead to severe outcomes in cases of Covid-19, and/or age above 60.
According to a statement issued, the treatment given to the patients was personalised (in accordance with the classical texts) and took account of each patient’s medical history and the symptoms presented, which made it more effective as compared to a fixed standardised treatment plan.
The treatment included ayurvedic medicines, daily yoga-sessions, including deep relaxation techniques, pranayama and basic asanas and some lifestyle modifications. Based on the administered treatment, the cases were categorised into YAS (Yoga-Ayurveda based treatment, with possibly allopathic supplements: four patients), YASP (Yoga-Ayurveda based treatment, with possibly allopathic supplements and Paracetamol: six patients), YAM (Yoga-Ayurveda based treatment, and Modern Western Medicine (MWM), i.e., allopathy as adjunct: six patients), MYA (first tried MWM, later switched to Yoga-Ayurveda: 14 patients).
The patients, most of whom presented with many symptoms prior to the yoga and ayurveda treatment, were followed-up telephonically regularly until recovery. More than half of symptomatic patients started improving within five days (90% within nine days); more than 60% reported at least 90% recovery within 10 days. Six patients with oxygen saturation (SpO2) below 95%, benefited through Makarasana and Shithilasana; none progressed to composite endpoints (consisting of admission to intensive care unit, invasive ventilation or death). Considering that approximately 19.3% of the patients with these comorbidities progress to composite end points, the p-value was found to be 7.21 x 10-3.
“Most patients reported that the therapy had a profound impact on their recovery process, with many experiencing improvements with respect to their comorbidities too. By the end of the treatment, several patients had decided to adopt yoga in their lifestyle, and several turned to the ayurveda doctors in the team for management/treatment of their comorbidities,” said Dr Sonika Thakral, IIT-Delhi, who coordinated with the patients for routine follow-up.
“We are observing an increasing trend towards ancient systems of medicine,” said Dr Yogesh Kumar, Advait Clinic, Delhi who also administered ayurveda treatment to some patients. The findings of the study have appeared in the Indian Journal of Traditional Knowledge. The authors point out that high-risk Covid-19 patients undergo severe anxiety, which may further deteriorate their condition.





Source link

Leave a Comment